-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Adjusts Zimmer Biomet Holdings' Price Target to $135 From $120, Keeps Equalweight Rating

Morgan Stanley Adjusts Zimmer Biomet Holdings' Price Target to $135 From $120, Keeps Equalweight Rating

MT Newswires · 01/06/2023 06:15